Teleflex (TFX)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
178.99
0.45 (0.25%)
At close: Jan 14, 2025, 3:59 PM
180.51
0.85%
Pre-market Jan 15, 2025, 06:13 AM EST
Teleflex Revenue Breakdown
Quarter | Sep 29, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Oct 1, 2023 | Jul 2, 2023 | Apr 2, 2023 | Dec 31, 2022 | Sep 25, 2022 | Jun 26, 2022 | Mar 27, 2022 | Dec 31, 2021 | Sep 26, 2021 | Jun 27, 2021 | Mar 28, 2021 | Dec 31, 2020 | Sep 27, 2020 | Jun 28, 2020 | Mar 29, 2020 | Dec 31, 2019 | Sep 29, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jul 1, 2018 | Apr 1, 2018 | Dec 31, 2017 | Oct 1, 2017 | Jul 2, 2017 | Apr 2, 2017 | Dec 31, 2016 | Sep 25, 2016 | Jun 26, 2016 | Mar 27, 2016 | Dec 31, 2015 | Jun 28, 2015 | Mar 29, 2015 | Dec 31, 2014 | Sep 28, 2014 | Dec 31, 2011 | Sep 25, 2011 | Jun 26, 2011 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anesthesia Revenue | 101.15M | 102.49M | 96.35M | 98.17M | 97.61M | 100.84M | 93.33M | 99.63M | 97.61M | 104.69M | 86.96M | 102.78M | 97.07M | 95.43M | 84.86M | 86.08M | 75.65M | 64.87M | 75.70M | 85.31M | 87.12M | 85.72M | 80.25M | 86.17M | 87.97M | 89.81M | 85.42M | 0 | 99.61M | 100.21M | 76.85M | 60.98M | 53.13M | 57.92M | 53.18M | 107.43M | 55.69M | 55.54M | 172.91M | 60.20M | 600.00K | 219.00K | 234.00K |
Anesthesia Revenue Growth | -1.30% | +6.37% | -1.85% | +0.57% | -3.20% | +8.05% | -6.32% | +2.07% | -6.77% | +20.40% | -15.40% | +5.88% | +1.73% | +12.46% | -1.42% | +13.79% | +16.62% | -14.31% | -11.27% | -2.08% | +1.63% | +6.82% | -6.87% | -2.05% | -2.05% | +5.14% | n/a | -100.00% | -0.60% | +30.40% | +26.03% | +14.77% | -8.27% | +8.91% | -50.50% | +92.90% | +0.26% | -67.88% | +187.22% | +9933.33% | +173.97% | -6.41% | n/a |
Interventional Urology Revenue | 83.39M | 83.10M | 79.74M | 92.97M | 73.62M | 77.82M | 75.38M | 89.15M | 78.97M | 79.82M | 74.89M | 92.95M | 83.11M | 92.24M | 73.36M | 93.96M | 81.77M | 40.09M | 74.19M | 89.14M | 73.63M | 67.95M | 59.73M | 57.77M | 48.99M | 47.67M | 42.30M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 138.55M | 66.00M | 72.89M |
Interventional Urology Revenue Growth | +0.35% | +4.22% | -14.22% | +26.27% | -5.39% | +3.24% | -15.45% | +12.89% | -1.06% | +6.57% | -19.42% | +11.84% | -9.90% | +25.73% | -21.92% | +14.90% | +103.95% | -45.96% | -16.76% | +21.06% | +8.35% | +13.76% | +3.40% | +17.90% | +2.77% | +12.70% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | +109.94% | -9.46% | n/a |
Interventional Revenue | 149.87M | 141.16M | 134.66M | 135.67M | 134.09M | 124.78M | 116.90M | 125.08M | 108.74M | 114.34M | 96.86M | 114.94M | 104.30M | 112.08M | 96.17M | 106.72M | 93.19M | 82.59M | 99.93M | 112.71M | 106.88M | 104.78M | 103.18M | 167.16M | 79.40M | 77.18M | 71.68M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interventional Revenue Growth | +6.17% | +4.82% | -0.74% | +1.18% | +7.46% | +6.74% | -6.54% | +15.03% | -4.90% | +18.05% | -15.73% | +10.20% | -6.94% | +16.54% | -9.89% | +14.53% | +12.83% | -17.35% | -11.34% | +5.45% | +2.00% | +1.55% | -38.27% | +110.52% | +2.88% | +7.67% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Revenue | 54.76M | 41.70M | 52.52M | 68.26M | 76.03M | 75.95M | 71.65M | 73.59M | 69.91M | 72.14M | 69.51M | 84.68M | 83.38M | 86.84M | 81.68M | 98.08M | 86.02M | 91.41M | 91.74M | 89.37M | 83.94M | 88.40M | 85.56M | 37.40M | 105.84M | 111.52M | 112.09M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Revenue Growth | +31.31% | -20.58% | -23.07% | -10.22% | +0.11% | +6.00% | -2.63% | +5.25% | -3.08% | +3.77% | -17.92% | +1.57% | -3.99% | +6.32% | -16.72% | +14.03% | -5.90% | -0.35% | +2.65% | +6.47% | -5.05% | +3.32% | +128.77% | -64.66% | -5.09% | -0.51% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Surgical Revenue | 111.75M | 111.30M | 105.52M | 109.58M | 112.81M | 105.95M | 99.02M | 110.45M | 93.12M | 99.64M | 89.70M | 106.35M | 92.83M | 98.19M | 80.39M | 92.27M | 82.22M | 67.28M | 75.43M | 95.16M | 92.62M | 95.57M | 86.72M | 92.68M | 89.91M | 90.49M | 85.63M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Surgical Revenue Growth | +0.40% | +5.48% | -3.70% | -2.86% | +6.47% | +7.00% | -10.35% | +18.60% | -6.54% | +11.08% | -15.66% | +14.57% | -5.45% | +22.14% | -12.88% | +12.22% | +22.22% | -10.81% | -20.73% | +2.75% | -3.09% | +10.21% | -6.43% | +3.08% | -0.64% | +5.67% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Vascular Access Revenue | 180.90M | 181.10M | 181.35M | 186.69M | 169.92M | 173.78M | 177.65M | 186.42M | 167.15M | 163.91M | 166.13M | 193.05M | 175.48M | 167.74M | 163.97M | 182.44M | 160.05M | 164.96M | 150.26M | 154.65M | 148.68M | 153.65M | 143.90M | 147.77M | 142.71M | 140.60M | 144.24M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Vascular Access Revenue Growth | -0.12% | -0.14% | -2.86% | +9.87% | -2.22% | -2.18% | -4.71% | +11.53% | +1.98% | -1.34% | -13.94% | +10.02% | +4.61% | +2.30% | -10.12% | +13.99% | -2.97% | +9.78% | -2.84% | +4.01% | -3.23% | +6.78% | -2.62% | +3.54% | +1.50% | -2.52% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
Quarter | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | Dec 31, 2018 | Dec 31, 2017 | Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | Dec 31, 2013 |
---|---|---|---|---|---|---|---|---|---|---|---|
Americas Segment Revenue | 1.72B | 1.65B | 1.66B | 1.47B | 241.28M | 286.89M | 269.21M | 249.42M | 241.73M | 237.70M | 800.46M |
Americas Segment Revenue Growth | +3.73% | -0.34% | +13.26% | +507.20% | -15.90% | +6.57% | +7.94% | +3.18% | +1.70% | -70.31% | n/a |
Asia Revenue | 346.90M | 306.32M | 297.77M | 267.02M | 652.07M | 603.81M | 552.72M | 510.93M | 514.44M | 593.07M | 207.21M |
Asia Revenue Growth | +13.25% | +2.87% | +11.52% | -59.05% | +7.99% | +9.24% | +8.18% | -0.68% | -13.26% | +186.22% | n/a |
Emea Revenue | 586.25M | 558.37M | 606.81M | 584.86M | n/a | 205.98M | 182.97M | 160.99M | 149.40M | 143.97M | 557.43M |
Emea Revenue Growth | +4.99% | -7.98% | +3.75% | n/a | n/a | +12.58% | +13.65% | +7.76% | +3.77% | -74.17% | n/a |
Oem Revenue | 326.01M | 272.62M | 245.68M | 220.25M | n/a | n/a | n/a | n/a | n/a | n/a | 131.17M |
Oem Revenue Growth | +19.58% | +10.97% | +11.55% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
Quarter | Sep 29, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Oct 1, 2023 | Jul 2, 2023 | Apr 2, 2023 | Dec 31, 2022 | Sep 25, 2022 | Jun 26, 2022 | Mar 27, 2022 | Dec 31, 2021 | Sep 26, 2021 | Jun 27, 2021 | Mar 28, 2021 | Dec 31, 2020 | Sep 27, 2020 | Jun 28, 2020 | Mar 29, 2020 | Dec 31, 2019 | Sep 29, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jul 1, 2018 | Apr 1, 2018 | Dec 31, 2017 | Oct 1, 2017 | Jul 2, 2017 | Apr 2, 2017 | Dec 31, 2016 | Sep 25, 2016 | Jun 26, 2016 | Mar 27, 2016 | Dec 31, 2015 | Sep 27, 2015 | Jun 28, 2015 | Mar 29, 2015 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selling, General, and Administrative Revenue | 247.26M | 250.63M | 242.83M | 260.65M | 213.19M | 223.31M | 232.72M | 233.38M | 208.62M | 216.93M | 203.93M | 227.58M | 205.19M | 224.16M | 203.15M | 232.91M | 171.67M | 191.19M | 147.80M | 240.60M | 229.90M | 236.19M | 227.69M | 218.54M | 214.89M | 229.92M | 215.34M | 213.29M | 163.77M | 158.93M | 163.97M | 144.18M | 139.80M | 142.98M | 136.35M | 148.22M | 138.84M | 142.23M | 139.70M |
Selling, General, and Administrative Revenue Growth | -1.35% | +3.21% | -6.84% | +22.26% | -4.53% | -4.04% | -0.28% | +11.87% | -3.83% | +6.37% | -10.39% | +10.91% | -8.46% | +10.34% | -12.78% | +35.67% | -10.21% | +29.36% | -38.57% | +4.66% | -2.66% | +3.73% | +4.19% | +1.70% | -6.53% | +6.77% | +0.96% | +30.24% | +3.04% | -3.07% | +13.73% | +3.14% | -2.23% | +4.87% | -8.01% | +6.75% | -2.38% | +1.81% | n/a |
Research and Development Revenue | 38.73M | 41.09M | 37.30M | 35.86M | 37.58M | 39.45M | 41.47M | 42.76M | 37.77M | 36.93M | 36.36M | 35.80M | 31.82M | 33.28M | 29.95M | 33.77M | 29.22M | 29.36M | 27.40M | 31.13M | 27.98M | 27.59M | 27.15M | 27.80M | 26.36M | 26.02M | 26.03M | 25.47M | 21.19M | 20.28M | 17.83M | 15.69M | 15.07M | 15.47M | 12.35M | 13.22M | 12.57M | 13.44M | 12.88M |
Research and Development Revenue Growth | -5.76% | +10.17% | +4.02% | -4.57% | -4.75% | -4.87% | -3.01% | +13.20% | +2.26% | +1.58% | +1.58% | +12.51% | -4.41% | +11.14% | -11.32% | +15.58% | -0.50% | +7.18% | -11.99% | +11.23% | +1.41% | +1.64% | -2.33% | +5.44% | +1.33% | -0.03% | +2.18% | +20.18% | +4.52% | +13.75% | +13.64% | +4.11% | -2.62% | +25.25% | -6.57% | +5.17% | -6.49% | +4.34% | n/a |